Journal profile · Oncology
Current Opinion in Oncology
ISSN 1040-8746 · eISSN 1531-703X · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1989
Current Opinion in Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.41; hybrid open access; review 4–8 weeks (community reports); community-reported acceptance: moderate; 89 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Opinion in Oncology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Head and Neck Cancer Studies, together about 20.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.
Source: LetPub
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine8.3%
- Lung Cancer Treatments and MutationsMedicine6.4%
- Head and Neck Cancer StudiesMedicine5.8%
- Sarcoma Diagnosis and TreatmentMedicine5.6%
- Lung Cancer Research StudiesMedicine5.1%
- Glioma Diagnosis and TreatmentMedicine4.6%
- Cancer Immunotherapy and BiomarkersMedicine4.4%
- Viral-associated cancers and disordersMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.41LetPub ·
- CiteScore 2026-06
- 4.8LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 0.75LetPub ·
- h-index
- 86LetPub ·
- h-index
- 119OpenAlex ·
- i10-index
- 2,036OpenAlex ·
- 2-year mean citedness
- 2.79OpenAlex ·
- Self-citation rate
- 4.2%LetPub ·
- Share of gold OA articles
- 12.6%LetPub ·
Volume
- Articles per year
- 85LetPub ·
Articles by year OpenAlex count · 3,888 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 61 | 10 | 14 |
| 2025 | 89 | 23 | 197 |
| 2024 | 96 | 20 | 475 |
| 2023 | 84 | 18 | 590 |
| 2022 | 103 | 34 | 1,063 |
| 2021 | 97 | 22 | 1,250 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1989
- ISSN
- 1040-8746
- Electronic ISSN
- 1531-703X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Opinion in Oncology
What CAS zone is Current Opinion in Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Opinion in Oncology is in Zone 3 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Opinion in Oncology?
The latest impact factor listed by LetPub is 2.41; CiteScore 4.8, h-index 119.
How long does peer review take at Current Opinion in Oncology?
Authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Opinion in Oncology?
According to LetPub and DOAJ records, Current Opinion in Oncology is indexed in SCIE and Scopus.
Is Current Opinion in Oncology open access, and what is the APC?
Current Opinion in Oncology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .